Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $126.85 billion. The enterprise value is $117.40 billion.
| Market Cap | 126.85B |
| Enterprise Value | 117.40B |
Important Dates
The next confirmed earnings date is Thursday, August 1, 2024, after market close.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 258.05 million shares outstanding. The number of shares has increased by 0.31% in one year.
| Shares Outstanding | 258.05M |
| Shares Change (YoY) | +0.31% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 95.89% |
| Float | 257.31M |
Valuation Ratios
The trailing PE ratio is 31.90 and the forward PE ratio is 28.81. VRTX's PEG ratio is 0.53.
| PE Ratio | 31.90 |
| Forward PE | 28.81 |
| PS Ratio | 12.45 |
| Forward PS | 11.52 |
| PB Ratio | 6.84 |
| P/FCF Ratio | 34.12 |
| PEG Ratio | 0.53 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.45, with an EV/FCF ratio of 31.58.
| EV / Earnings | 29.21 |
| EV / Sales | 11.53 |
| EV / EBITDA | 23.45 |
| EV / EBIT | 24.41 |
| EV / FCF | 31.58 |
Financial Position
The company has a current ratio of 3.50, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.50 |
| Quick Ratio | 3.15 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.19 |
| Interest Coverage | 111.61 |
Financial Efficiency
Return on equity (ROE) is 23.60% and return on invested capital (ROIC) is 18.13%.
| Return on Equity (ROE) | 23.60% |
| Return on Assets (ROA) | 18.10% |
| Return on Capital (ROIC) | 18.13% |
| Revenue Per Employee | $1.89M |
| Profits Per Employee | $744,333 |
| Employee Count | 5,400 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.98 |
Taxes
In the past 12 months, VRTX has paid $748.00 million in taxes.
| Income Tax | 748.00M |
| Effective Tax Rate | 15.69% |
Stock Price Statistics
The stock price has increased by +37.09% in the last 52 weeks. The beta is 0.39, so VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +37.09% |
| 50-Day Moving Average | 465.85 |
| 200-Day Moving Average | 414.18 |
| Relative Strength Index (RSI) | 66.23 |
| Average Volume (20 Days) | 1,232,612 |
Short Selling Information
The latest short interest is 4.10 million, so 1.59% of the outstanding shares have been sold short.
| Short Interest | 4.10M |
| Short Previous Month | 4.47M |
| Short % of Shares Out | 1.59% |
| Short % of Float | 1.59% |
| Short Ratio (days to cover) | 2.99 |
Income Statement
In the last 12 months, VRTX had revenue of $10.19 billion and earned $4.02 billion in profits. Earnings per share was $15.41.
| Revenue | 10.19B |
| Gross Profit | 8.85B |
| Operating Income | 4.14B |
| Pretax Income | 4.77B |
| Net Income | 4.02B |
| EBITDA | 5.01B |
| EBIT | 4.81B |
| Earnings Per Share (EPS) | $15.41 |
Balance Sheet
The company has $10.17 billion in cash and $721.30 million in debt, giving a net cash position of $9.45 billion or $36.62 per share.
| Cash & Cash Equivalents | 10.17B |
| Total Debt | 721.30M |
| Net Cash | 9.45B |
| Net Cash Per Share | $36.62 |
| Equity (Book Value) | 18.55B |
| Book Value Per Share | 71.87 |
| Working Capital | 9.49B |
Cash Flow
In the last 12 months, operating cash flow was $3.94 billion and capital expenditures -$226.70 million, giving a free cash flow of $3.72 billion.
| Operating Cash Flow | 3.94B |
| Capital Expenditures | -226.70M |
| Free Cash Flow | 3.72B |
| FCF Per Share | $14.40 |
Margins
Gross margin is 86.86%, with operating and profit margins of 40.67% and 39.46%.
| Gross Margin | 86.86% |
| Operating Margin | 40.67% |
| Pretax Margin | 46.81% |
| Profit Margin | 39.46% |
| EBITDA Margin | 49.16% |
| EBIT Margin | 47.23% |
| FCF Margin | 36.50% |
Dividends & Yields
VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.31% |
| Shareholder Yield | -0.31% |
| Earnings Yield | 3.17% |
| FCF Yield | 2.93% |
Analyst Forecast
The average price target for VRTX is $459.59, which is -6.51% lower than the current price. The consensus rating is "Buy".
| Price Target | $459.59 |
| Price Target Difference | -6.51% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (5Y) | 9.91% |
| EPS Growth Forecast (5Y) | 12.79% |
Stock Splits
The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 24, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
VRTX has an Altman Z-Score of 16.4 and a Piotroski F-Score of 4.
| Altman Z-Score | 16.4 |
| Piotroski F-Score | 4 |